-
1دورية أكاديمية
المؤلفون: Eriko Fujimoto, Takashi Yokoi, Koji Mikami, Shingo Kanemura, Eisuke Shibata, Daisuke Horio, Yuichi Koda, Yoshiki Negi, Yumiko Akano, Akio Tada, Toshiyuki Minami, Kozo Kuribayashi, Takashi Kijima
المصدر: Case Reports in Oncology, Vol 11, Iss 2, Pp 336-340 (2018)
مصطلحات موضوعية: Pulmonary pleomorphic carcinoma, Nivolumab, Programmed cell death ligand-1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2دورية أكاديمية
المؤلفون: Akio Tada, Daisuke Horio, Eriko Fujimoto, Kozo Kuribayashi, Takashi Kijima, Takashi Yokoi, Toshiyuki Minami, Yoshiki Negi, Yuichi Koda, Yumiko Akano, 南 俊行, 堀尾 大介, 多田 陽郎, 幸田 裕一, 木島 貴志, 栗林 康造, 横井 崇, 祢木 芳樹, 藤本 英利子, 赤野 友美子
المصدر: 気管支学 / The Journal of the Japan Society for Respiratory Endoscopy. 2018, 40(5):489
-
3دورية أكاديمية
المؤلفون: Daisuke Horio, Eriko Fujimoto, Koshi Mase, Kozo Kuribayashi, Miki Honda, Ryuji Ieki, Shingo Kanemura, Taiichiro Otsuki, Takashi Nakano, Tomoko Nakamura, Yoshiki Negi, Yuichi Koda, Yumiko Moriya, 中村 智子, 中野 孝司, 堀尾 大介, 大搗 泰一郎, 守屋 友美子, 家城 隆次, 幸田 裕一, 本田 実紀, 栗林 康造, 祢木 芳樹, 藤本 英利子, 金村 晋吾, 間瀬 浩史
المصدر: 気管支学 / The Journal of the Japan Society for Respiratory Endoscopy. 2016, 38(1):48
-
4دورية أكاديمية
المؤلفون: Akihiro IZUMIDA, Hiroshi TAKUMA, Kazuhide TAWARA, Kazuo KODAMA, Makoto FURUKAWA, Michio KUBOTA, Yuichi KODA, 久保田 道雄, 児玉 和夫, 出水田 昭弘, 古川 誠, 幸田 祐一, 田原 和英, 詫間 博
المصدر: 日本獸醫學雜誌(The Japanese Journal of Veterinary Science) / The Japanese Journal of Veterinary Science. 1986, 48(2):293
-
5دورية أكاديمية
المؤلفون: AKIHIRO IZUMIDA, HIROSHI TAKUMA, KAZUHIDE TAWARA, KAZUO KODAMA, MAKOTO FURUKAWA, MICHIO KUBOTA, YUICHI KODA, 久保田 道雄, 児玉 和夫, 出水田 昭弘, 古川 誠, 幸田 祐一, 田原 和英, 詫間 博
المصدر: 日本獣医師会雑誌 / Journal of the Japan Veterinary Medical Association. 1987, 40(4):275
-
6دورية أكاديمية
المؤلفون: Akira Konno, Toshifumi Kanamoto, Yoshikazu Iwasaki, Yuichi Koda, 小田 勇一, 岩崎 義一, 紺野 昭, 金元 利文
المصدر: 都市計画論文集 / Journal of the City Planning Institute of Japan. 1982, 17:55
-
7
المؤلفون: Kazuhiro Kitajima, Hirotoshi Ishigaki, Takashi Yokoi, Ryo Takahashi, Hiroshi Doi, Toshiyuki Minami, Akifumi Nakamura, Yasuhiro Nakajima, Takashi Kijima, Yuichi Koda, Kozo Kuribayashi
المصدر: Oncology. 99:161-168
مصطلحات موضوعية: Male, Antimetabolites, Antineoplastic, Cancer Research, medicine.medical_specialty, Neutropenia, Combination therapy, medicine.medical_treatment, Kaplan-Meier Estimate, Pemetrexed, Irinotecan, Deoxycytidine, Gastroenterology, chemistry.chemical_compound, Japan, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Aged, Platinum, Retrospective Studies, Chemotherapy, business.industry, Mesothelioma, Malignant, Combination chemotherapy, Leukopenia, General Medicine, Middle Aged, medicine.disease, Thrombocytopenia, Gemcitabine, Progression-Free Survival, Carboplatin, Oncology, chemistry, Female, business, Progressive disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d00526a1bba81296ca6a4a7a786352cdTest
https://doi.org/10.1159/000510691Test -
8
المؤلفون: Hirotoshi Ishigaki, Nobuyuki Kondo, Koji Mikami, Takashi Kijima, Kazuhiro Kitajima, Shingo Kanemura, Yasuhiro Nakajima, Maiko Niki, Toshiyuki Minami, Daisuke Horio, Eisuke Shibata, Seiichi Hirota, Yuichi Koda, Eriko Fujimoto, Yoshiki Negi, Ryo Takahashi, Kozo Kuribayashi, Takashi Yokoi, Yoko Higashiguchi, Hidemi Kitai
المصدر: Cancer Science
مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Inflammasomes, Biopsy, medicine.medical_treatment, Interleukin-1beta, tumor‐associated macrophage, IL‐1β, Pemetrexed, Tumor-associated macrophage, 03 medical and health sciences, 0302 clinical medicine, Cell, Molecular, and Stem Cell Biology, inflammasome, Cancer stem cell, Cell Line, Tumor, Spheroids, Cellular, Antineoplastic Combined Chemotherapy Protocols, Tumor Microenvironment, medicine, Humans, malignant pleural mesothelioma, Aged, Receptors, Interleukin-1 Type I, Cisplatin, business.industry, Macrophages, Mesothelioma, Malignant, Asbestos, Combination chemotherapy, Original Articles, General Medicine, Middle Aged, Up-Regulation, Regimen, 030104 developmental biology, Cytokine, Oncology, 030220 oncology & carcinogenesis, Cancer research, Pleura, Immunohistochemistry, Female, Original Article, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::715172eb52ee4b1c66557081598738dbTest
https://doi.org/10.1111/cas.14523Test -
9
المؤلفون: Shingo Kanemura, Maiko Niki, Yasuhiro Nakajima, Takashi Kijima, Osamu Morimura, Hidemi Kitai, Hirotoshi Ishigaki, Eisuke Shibata, Eriko Fujimoto, Ryo Takahashi, Toshiyuki Minami, Koji Mikami, Takashi Yokoi, Yoshiki Negi, Daisuke Horio, Yuichi Koda, Kozo Kuribayashi
المصدر: Biochemical and Biophysical Research Communications. 519:846-853
مصطلحات موضوعية: Niacinamide, 0301 basic medicine, Lung Neoplasms, Cell cycle checkpoint, medicine.medical_treatment, Dasatinib, Biophysics, Antineoplastic Agents, Neuroendocrine tumors, Biochemistry, Structure-Activity Relationship, 03 medical and health sciences, 0302 clinical medicine, Downregulation and upregulation, Tumor Cells, Cultured, Humans, Medicine, Lung cancer, neoplasms, Molecular Biology, Cell Proliferation, Chemotherapy, business.industry, Receptor, EphA2, Ephrin-A2, Cell Cycle Checkpoints, Cell Biology, medicine.disease, EPH receptor A2, Small Cell Lung Carcinoma, humanities, respiratory tract diseases, 030104 developmental biology, Cell culture, 030220 oncology & carcinogenesis, Benzamides, Cancer research, Drug Screening Assays, Antitumor, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f8fd5d052934c45d646d11e9241c4e2Test
https://doi.org/10.1016/j.bbrc.2019.09.076Test -
10
المؤلفون: Norihiko Funaguchi, Ryo Takahashi, Toshiyuki Minami, Takashi Kijima, Takashi Yokoi, Yumiko Akano, Eriko Fujimoto, Koji Mikami, Yuichi Koda, Kozo Kuribayashi
المصدر: In Vivo. 33:507-514
مصطلحات موضوعية: Adult, Male, Oncology, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, Programmed Cell Death 1 Receptor, Antineoplastic Agents, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, 0302 clinical medicine, Recurrent Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Internal medicine, medicine, Humans, In patient, Adverse effect, Aged, Aged, 80 and over, Pharmacology, business.industry, Therapeutic effect, Middle Aged, Rash, Progression-Free Survival, Nivolumab, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, medicine.symptom, business, Research Article
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ed57510d6c8190b0257d09af0bfdb2Test
https://doi.org/10.21873/invivo.11503Test